Get Live Data

Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Porvair Share Price
  4. Porvair Share Regulatory News
  5. Total Voting Rights

Pin to quick picksPorvair Regulatory News (PRV)

Porvair Information

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 608.00
Bid: 610.00
Ask: 616.00
Change: -8.00 (-1.30%)
Spread: 6.00 (0.984%)
Open: 616.00
High: 628.00
Low: 608.00
Prev. Close: 616.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Nov 2022 07:00

RNS Number : 8177E
Porvair PLC
01 November 2022
 

1 November 2022

 

Porvair plc

("Porvair" or the "Company")

 

Total Voting Rights

 

The Company's issued share capital consists of 46,274,206 ordinary shares of 2 pence each with voting rights. Therefore, the total number of voting rights in the Company is 46,274,206. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, under section 89A(1) of the Financial Services and Markets Act 2000, as amended.

 

For more information, contact:

 

Porvair plc

Chris Tyler, Company Secretary

01553 765 500

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRMBBMTMTBJTJT
234567891011
Date   Source Headline
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company
26th Jun 20137:00 amRNSDirectors' Shareholdings and Issue of Equity
24th Jun 20136:17 pmRNSHolding(s) in Company
24th Jun 20137:00 amRNSInterim Results
21st Jun 20139:02 amRNSBlocklisting application
5th Jun 20137:00 amRNSAcquisition and Trading Update
31st May 201312:01 pmRNSTotal Voting Rights
16th Apr 20134:02 pmRNSDirectors' Shareholdings and Issue of Equity
16th Apr 20132:39 pmRNSAGM resolutions and notice of filings
16th Apr 20137:00 amRNSAGM Statement, IMS and Contract extension
28th Feb 201310:00 amRNSTotal Voting Rights
13th Feb 20137:00 amRNSContract Win
5th Feb 20136:16 pmRNSHolding(s) in Company
5th Feb 20134:40 pmRNSHolding(s) in Company
28th Jan 201312:28 pmRNSBlocklisting Application
28th Jan 20137:00 amRNSResults for the year ended 30 November 2012
11th Jan 20137:00 amRNSContract Win
30th Nov 20128:48 amRNSHolding(s) in Company
29th Nov 201211:32 amRNSHolding(s) in Company
29th Nov 201210:29 amRNSDirector/PDMR Shareholding
28th Nov 20127:00 amRNSPre-close trading update
28th Sep 201212:34 pmRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSInterim Management Statement
234567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.